Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients
Brandon W. Higgs(Parker Institute for Cancer Immunotherapy), Yihong Yao(University of Science and Technology Beijing), David Fiorentino(Stanford University), Steven A. Greenberg(Brigham and Women's Hospital), Wei Zhu(Ministry of Education of the People's Republic of China), Bahija Jallal(Unknown), Laura K. Richman(University of Pennsylvania)
Cited by 60
Related Papers
Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI.
|Proceedings of the National Academy of Sciences|1991|752
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
|Cell|2020|546
Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
|Annals of the Rheumatic Diseases|2011|412
Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle
|Proceedings of the National Academy of Sciences|2002|365
Type I Interferon: Potential Therapeutic Target for Psoriasis?
|PLoS ONE|2008|308